AADI (Aadi Bio) Margin bathi reged

Lambang korporat lan logo Aadi Bioscience (AADI)

Aadi Bioscience delegates drug manufacturing and testing to external contractors to maintain flexibility. The primary focus is on the academic environment and the development of targeted mTOR inhibitors, where scientists are incentivized by stock options. The consistent performance of partner laboratories confirms the effectiveness of this model. The current gross margin demonstrates financial stability, with the indicator standing at 87.40.

AADI - Tingkat bathi miturut bathi reged Aadi Bio ing rentang 04.07.2022 - 19.03.2025

Rincian metrik keuangan lan pasar Aadi Bio (AADI)

- rega saham lan prakiraan rega para ahli:
- indikator valuasi pasar bisnis:
Pambiji fundamental:AADI aadibio.com
Barang unggulan Aadi Bioscience Inc

Gross margin determines production efficiency by measuring the portion of revenue remaining after direct product creation costs. Stable utilization of biotechnological complexes and the absence of downtime in contract drug manufacturing are reflected in the consolidated gross margin trend for Aadi Bioscience (AADI). Analyzing this metric allows investors to assess the asset's operating profitability and determine the company's fair cost of capital.